As of 2025-09-09, the Fair Value of Outlook Therapeutics Inc (OTLK) is -4.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.93 USD, the upside of Outlook Therapeutics Inc is -627.83%.
With the market price of 0.93 USD and our fair value calculation, Outlook Therapeutics Inc (OTLK) is not a good investment. Investing in OTLK stocks now will result in a potential loss of 627.83%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 5Y Avg | |
| Net income | -35.24 | -53.16 | -66.05 | -58.98 | -75.00 | -57.69 |
| YoY growth | -2.07% | -50.86% | -24.24% | 10.70% | -27.16% | -18.73% |
| Market Cap (mil) | 41.15 |
| P/E | |
| Forward P/E |
| EPS | -0.98 |
| Avg earnings growth rate | -18.73% |
| TTM earnings | -43.44 |